Skip to Content

MAP - 5 (50 mg)

This page contains information on MAP - 5 (50 mg) for veterinary use.
The information provided typically includes the following:
  • MAP - 5 (50 mg) Indications
  • Warnings and cautions for MAP - 5 (50 mg)
  • Direction and dosage information for MAP - 5 (50 mg)

MAP - 5 (50 mg)

This treatment applies to the following species:
Manufacturer: Vetoquinol USA

Sterile Sodium Hyaluronate Cryopreservative (5 mg/mL)

Each vial contains: sodium hyaluronate 50.0 mg, sodium chloride USP 85.0 mg, sodium phosphate monobasic dihydrate 0.5 mg, sodium phosphate bibasic dodecahydrate 6.0 mg, water for injection USP q.s. 10 mL. Contains no preservatives. Store at 10-30°C.

Vetoquinol N.-A. Inc., Lavaltrie, QC, Canada

Vetoquinol USA, Inc., Fort Worth, TX, USA

10 mL

439263 2

NAC No.: 1005111.0

VETOQUINOL USA, INC.
4250 N. SYLVANIA AVENUE, FORT WORTH, TX, 76137
Customer Service:   800-267-5707
Website:   www.vetoquinolusa.com
Email:   info@vetoquinolusa.com
Every effort has been made to ensure the accuracy of the MAP - 5 (50 mg) information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2016 North American Compendiums. Updated: 2016-10-31

Hide